Automated calculation of point A coordinates for CT-based high-dose-rate brachytherapy of cervical cancer

Por Kang, Hyejoo, Padilla, Laura, Hasan, Yasmin, Al-Hallaq, Hania
Publicado no J Contemp Brachytherapy (2017)

Utilization Trend and Regimens of Hypofractionated Whole Breast Radiation Therapy in the United States

Por Hasan, Yasmin, Waller, Joseph, Yao, Katharine, Chmura, Steven J., Huo, Dezheng
Publicado no Breast Cancer Res Treat (2017)

Simultaneously integrated boost (SIB) spares OAR and reduces treatment time in locally advanced cervical cancer

Por Feng, Christine H., Hasan, Yasmin, Kopec, Malgorzata, Al‐Hallaq, Hania A.
Publicado no J Appl Clin Med Phys (2016)

Effect of RTOG breast/chest wall guidelines on dose‐volume histogram parameters

Por Rudra, Sonali, Al‐Hallaq, Hania A., Feng, Christine, Chmura, Steven J., Hasan, Yasmin
Publicado no J Appl Clin Med Phys (2014)

Assessment of interfractional variation of the breast surface following conventional patient positioning for whole‐breast radiotherapy

Por Padilla, Laura, Kang, Hyejoo, Washington, Maxine, Hasan, Yasmin, Chmura, Steve J., Al‐Hallaq, Hania
Publicado no J Appl Clin Med Phys (2014)

An image-guided study of setup reproducibility of post-mastectomy breast cancer patients treated with inverse-planned intensity-modulated radiation therapy (IMRT)

Por Feng, Huiting Christine, Gerry, Emily, Chmura, Steven J., Hasan, Yasmin, Al-Hallaq, Hania A.
Publicado no Int J Radiat Oncol Biol Phys (2014)

Long-Term Outcomes in Patients with Early Stage Nodular Lymphocyte-Predominant Hodgkin’s Lymphoma Treated with Radiotherapy

Por Solanki, Abhishek A., LeMieux, Melissa Horoschak, Chiu, Brian C.-H., Mahmood, Usama, Hasan, Yasmin, Koshy, Matthew
Publicado em 2013

A Prospective Study of the Utility of Magnetic Resonance Imaging in Determining Candidacy for Partial Breast Irradiation

Por Dorn, Paige L., Al-Hallaq, Hania A., Haq, Farah, Goldberg, Mira, Abe, Hiroyuki, Hasan, Yasmin, Chmura, Steven J.
Publicado no Int J Radiat Oncol Biol Phys (2012)

The efficacy and safety of continued hydroxycarbamide therapy versus switching to ruxolitinib in patients with polycythaemia vera: a randomized, double‐blind, double‐dummy, symptom...

Por Mesa, Ruben, Vannucchi, Alessandro M., Yacoub, Abdulraheem, Zachee, Pierre, Garg, Mamta, Lyons, Roger, Koschmieder, Steffen, Rinaldi, Ciro, Byrne, Jennifer, Hasan, Yasmin, Passamonti, Francesco, Verstovsek, Srdan, Hunter, Deborah, Jones, Mark M., Zhen, Huiling, Habr, Dany, Martino, Bruno
Publicado no Br J Haematol (2016)

CHOP versus GEM-P in previously untreated patients with peripheral T-cell lymphoma (CHEMO-T): a phase 2, multicentre, randomised, open-label trial

Por Gleeson, Mary, Peckitt, Clare, To, Ye Mong, Edwards, Laurice, Oates, Jacqueline, Wotherspoon, Andrew, Attygalle, Ayoma D, Zerizer, Imene, Sharma, Bhupinder, Chua, Sue, Begum, Ruwaida, Chau, Ian, Johnson, Peter, Ardeshna, Kirit M, Hawkes, Eliza A, Macheta, Marian P, Collins, Graham P, Radford, John, Forbes, Adam, Hart, Alistair, Montoto, Silvia, McKay, Pamela, Benstead, Kim, Morley, Nicholas, Kalakonda, Nagesh, Hasan, Yasmin, Turner, Deborah, Cunningham, David
Publicado no Lancet Haematol (2018)